Stock market today: Dow in fresh record close as Powell signals rate cut incoming
Constantine Chinoporos, the Chief Operating Officer and Chief Business Officer at Applied Therapeutics, Inc. (NASDAQ:APLT), recently reported a sale of company stock. On March 4, 2025, Chinoporos sold 447 shares of common stock at a price of $0.44 per share, totaling $196. The transaction occurred as the company’s stock trades near its 52-week low of $0.43, having declined over 90% in the past year. With a market capitalization of $58 million, InvestingPro analysis suggests the stock is currently undervalued. This transaction was conducted to cover tax withholding obligations related to the vesting of compensatory Restricted Stock Units, as noted in the filing.
Following this transaction, Chinoporos holds 271,436 shares directly. This sale was not a discretionary transaction but was executed to satisfy tax obligations.
In other recent news, Applied Digital Corporation reported fiscal second-quarter results that exceeded analyst expectations, with revenue and adjusted earnings surpassing projections. The company posted adjusted earnings per share of -$0.06, better than the anticipated -$0.14, and revenue reached $63.9 million, marking a 51% increase year-over-year. The Cloud Services segment was a significant growth driver, with revenue surging 523% year-over-year to $27.7 million. Additionally, Applied Digital announced a $5 billion perpetual preferred equity financing facility with Macquarie Asset Management to bolster its high-performance computing business. The company did not provide specific future financial guidance but expressed optimism about increasing demand for power and data centers.
In other developments, Applied Therapeutics, Inc. received a notification from the Nasdaq Stock Market regarding non-compliance with the minimum bid price requirement. The company’s stock has been below the $1.00 minimum bid price for 30 consecutive business days, putting its Nasdaq listing at risk. Applied Therapeutics has until August 6, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. The company is currently evaluating its options to address the issue, with no guarantee of achieving compliance or maintaining other Nasdaq listing standards. Investors are advised to keep an eye on these developments, as they could impact the company’s financial stability and market presence.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.